Witnesses
Thursday 9 September 2004
| Dr Felicity Harvey, Head of Medicines, Pharmacy and Industry Group, Dr Jim Smith, Chief Pharmaceutical Officer, Professor Sally Davies, Director of Research and Development, Department of Health, Professor Kent Woods, Chief Executive, Medicines and Healthcare products Regulatory Agency, and Dr Monica Darnbrough, Director, Bioscience Unit, Department of Trade and Industry.
| |
| |
| |
Thursday 14 October 2004
Dr Des Spence, UK Spokesperson, No Free Lunch, Mr Graham Vidler, Head, Policy, Consumer's Association (Which?), Dr Ike Iheanacho, Editor, Drug and Therapeutics Bulletin, and Dr Peter Wilmshurst, Consultant Cardiologist, Royal Shrewsbury Hospital
Mr Richard Brook, Chief Executive, Mind, Professor David Healy, Cardiff University, and Professor Andrew Herxheimer, Emeritus Fellow, UK Cochrane Centre, Oxford
| |
| |
| |
| |
| |
| |
| |
Thursday 11 November 2004
| Dr Iona Heath, Past Chairman, Committee on Medical Ethics, Royal College of General Practitioners, Dr Tim Kendall, Deputy Director, Royal College of Psychiatrists Research Unit, Mr Matt Griffiths, Senior Charge Nurse and Joint Prescribing Adviser, Royal College of Nursing, Mr John D'Arcy, Chief Executive, National Pharmaceutical Association, Mr Rob Darracott, Director, Corporate and Strategic Development, Royal Pharmaceutical Society of Great Britain and Dr Richard Nicholson, Editor, Bulletin of Medical Ethics
| |
| |
| |
| |
| |
| |
Thursday 25 November 2004
| Ms Melinda Letts, Chairman, Committee on Safety of Medicines Working Group on Patient Information and Paul Flynn MP, Chairman, Commons All-Party Group on Rheumatoid Arthritis
| |
| |
| |
Mr Phil Woolas MP, Trustee, Beat the Benzos Campaign and Mr Cliff Prior, Chief Executive, Rethink Severe Mental Illness, Mr Jim Thomson, Chief Executive, Depression Alliance, Mr Glynn McDonald, Head, Policy and Campaigns, Multiple Sclerosis Society, Dr Helen Wallace, Deputy Director, GeneWatch UK and Ms Jenny Hirst, Co-Chairman, Insulin-Dependent Diabetes Trust
| |
| |
| |
| |
| |
| |
Thursday 2 December 2004
| Sir Richard Sykes, Rector, Imperial College, London, Professor Patrick Vallance, Professor, Clinical Pharmacology and Head, Department of Medicine, University College, London and Sir Iain Chalmers, Editor, The James Lind Library
| |
| |
| |
| |
| Dr Roberto Solari, Chief Executive Officer, MRC Technology, Medical Research Council, Dr Malcolm Boyce, Chairman, Association for Human Pharmacology in the Pharmaceutical Industry and Mr Harpal Kumar, Chief Operating Officer, Cancer Research UK and Chief Executive Officer, Cancer Research Technology
| |
| |
| |
Thursday 16 December 2004
| Ms Margot James, European President, Ogilvy Healthworld, Mr Mike Paling, Managing Director, Paling Walters, Mr Richard Horton, Editor, The Lancet, Ms Jenny Hope, Medical Correspondent, Daily Mail and Ms Lois Rogers, Medical Editor, Sunday Times
| |
| |
| |
Thursday 13 January 2005
| Mr Eddie Gray, Senior Vice President and General Manager, and Dr Stuart Dollow, Vice President, Medical Division, GlaxoSmithKline, Mr Chris Brinsmead, Marketing Co-President and Dr John Patterson, Executive Director, Deveopment, AstraZeneca
| |
| |
| |
| |
| Dr Richard Barker, Director General, and Mr Vincent Lawton, President, Association of the British Pharmaceutical Industry, Dr David Chiswell, Chairman, BioIndustry Association and Mr Simon Clark, Chairman, British Generic Manufacturers Association
| |
| |
| |
Tuesday 20 January 2005
| Professor Sir Alasdair Breckenridge, Chairman, Professor Kent Woods, Chief Executive, and Dr June Raine, Director, Post-Licensing Division, Medicines and Healthcare products Regulatory Agency
| |
| |
| Professor Sir Michael Rawlins, Chairman, and Mr Andrew Dillon CBE, Chief Executive, National Institute for Clinical Excellence
| |
Thursday 3 February 2005
| The Lord Warner, Parliamentary Under-Secretary of State for Health [Lords], Dr Felicity Harvey, Head of Medicines, Pharmacy and Industry Group, Department of Health and Dr June Raine, Director, Post-Licensing Division, Medicines and Healthcare products Regulatory Agency
| |
|
